Suggested Topics within your search.
Suggested Topics within your search.
- Pediatric Nursing 2
- Anesthesia 1
- Anesthesiology 1
- Blood 1
- Blood Cell Count 1
- Blood Cells 1
- Blood Cells-Physiology 1
- Cancer 1
- Critical Care Nursing 1
- Critical Illness 1
- Diagnosis, Differential 1
- Diseases 1
- Hematologic Diseases 1
- Hematologic Tests-methods 1
- Hematology 1
- Intraoperative Complications 1
- Medicine 1
- Oncology 1
- Patient Harm 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- Physical therapy 1
- adverse effects 1
- methods 1
- nursing 1
- prevention & control 1
-
1281
Clinical integration of germline findings from a tumor testing precision medicine program
Published 2025-01-01Get full text
Article -
1282
-
1283
-
1284
Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients wit...
Published 2025-01-01“…<b>Background/Objectives:</b> Multiple Myeloma (MM) is a hematologic malignancy caused by clonally expanded plasma cells that produce a monoclonal immunoglobulin (M-protein), a personalized biomarker. …”
Get full text
Article -
1285
Differentiation of high risk prostate cancer with a facile urinary exosome detection workflow
Published 2025-02-01Get full text
Article -
1286
-
1287
-
1288
H2-K1 protects murine MLL-AF9 leukemia stem cells from natural killer cell-mediated immune surveillance
Published 2025-01-01Get full text
Article -
1289
-
1290
IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
Published 2025-01-01Get full text
Article -
1291
Conversion of placental hemogenic endothelial cells to hematopoietic stem and progenitor cells
Published 2025-01-01Get full text
Article -
1292
-
1293
IDH-mutant gliomas in children and adolescents - from biology to clinical trials
Published 2025-01-01Get full text
Article -
1294
-
1295
-
1296
-
1297
-
1298
-
1299
-
1300
Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment
Published 2010-01-01“…After treatment with hydroxyurea, interferon alpha, imatinib mesylate and dasatinib, or various combinations thereof, hematological remission was achieved in all patients and complete cytogenetic remission in nine of them. …”
Get full text
Article